ARCHES: A Multinational, Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

  • Liow, Elizabeth (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA Reference Number: HREC/16/HAWKE/66
SSA Reference Number: SSA/17/MonH/67
Monash Health HREC Ref: RES-17-0000098X
StatusFinished
Effective start/end date28/02/19 → 27/02/24

Clinical Trial Phase

  • Phase III (a & b)